Search papers, labs, and topics across Lattice.
This study introduces a Bayesian meta-learning framework for predicting Alzheimer's disease progression, addressing the limitations of classical regression models and single-task neural networks that struggle with individual-level correlations and sparse data. The proposed model dynamically tailors predictions based on an individual's historical data while avoiding the need for retraining, thus enhancing generalization across unseen individuals. Results demonstrate that the Bayesian meta-learner not only competes with existing models but also significantly improves long-term disease progression predictions using real-world data from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database.
Tailoring predictions to individual historical data, this Bayesian meta-learner significantly enhances long-term forecasting of Alzheimer's disease progression without retraining.
Predicting whether an individual with Alzheimer's disease will experience mild or severe disease progression is essential for personalized treatment. Typically, practitioners seek to predict the distribution of a discrete disease score, conditional on an individual's current MRI volume and their historical disease trajectory. Classical statistical regression models and single-task neural networks are not well-suited for this purpose because fitting separate models is infeasible (since each individual typically has few observations), while ignoring individual-level correlation leads to poor generalization. Meta-learning, in contrast, provides a natural avenue to dynamically predict distributions without retraining and model nonlinear relationships between the outcome and covariates. Motivated by this, we propose a Bayesian meta-learner that is trained on multiple individuals but tailors the predictive disease score distribution to each individual's historical data. Our model predicts on unseen individuals without retraining, scales linearly with the number of historical observations, and is guaranteed to be less overconfident when predicting long-term disease scores compared to its deterministic counterpart. On real-world data from the Alzheimer's Disease Neuroimaging Initiative (ADNI) database, our model achieves performance competitive with both single-task models and deterministic meta-learners, while substantially improving performance when predicting long-term disease progression.
